Search for dissertations about: "Genome editing"
Showing result 1 - 5 of 34 swedish dissertations containing the words Genome editing.
-
1. Understanding Cancer Mutations by Genome Editing
Abstract : Mutational analyses of cancer genomes have identified novel candidate cancer genes with hitherto unknown function in cancer. To enable phenotyping of mutations in such genes, we have developed a scalable technology for gene knock-in and knock-out in human somatic cells based on recombination-mediated construct generation and a computational tool to design gene targeting constructs. READ MORE
-
2. Improving integration efficiency and precision of CRISPR/Cas9-mediated genome editing
Abstract : The clustered regularly interspaced short palindromic repeats (CRISPR) – CRISPR-associated protein 9 (Cas9) system has revolutionized the field of genome engineering, providing a cost-effective and fast tool for targeted gene modifications. Endogenous repair pathways, including error-prone non-homologous end joining and alternative end joining, or precise homology-directed repair (HDR), mend Cas9-induced DNA double-strand breaks. READ MORE
-
3. Investigating the molecular mechanism of photoprotection, qH, in Arabidopsis thaliana
Abstract : Photoprotection mechanisms in plants play a crucial role in maintaining photosystem integrity and preventing photooxidative damage. In this study, we aimed to identify new molecular players involved in the qH process, a sustained photoprotective mechanism. READ MORE
-
4. Genome editing of oilseed species by CRISPR/Cas9 for trait improvement
Abstract : The demand for vegetable oils for food and other applications is rapidly increasing due to a growing population and an urgent need to replace fossil oils. Furthermore, there are several challenges facing agricultural production, such as a shortage of arable land, climate change, and water pollution due to nutrient leaching from extensive use of fertilizers and tillage. READ MORE
-
5. Targeting allelic loss in colorectal cancer
Abstract : Targeted cancer therapy exploits molecular differences between tumor and normal cells to selectively kill cancer cells. Whereas targeting of activated oncogenes has proved clinically useful, few current therapies exploit loss-of-function mutations in tumor suppressor genes or in the genome at large. READ MORE